Research programme: deuterium stabilised PUFAs- Retrotope

Drug Profile

Research programme: deuterium stabilised PUFAs- Retrotope

Alternative Names: 11,11-,14,14 tetra-deutero-linolenic acid ethyl ester, an omega 3 polyunsaturated fatty acid; RT 002 - Retrotope

Latest Information Update: 08 Nov 2016

Price : $50

At a glance

  • Originator Retrotope
  • Class Unsaturated fatty acids
  • Mechanism of Action Fatty acid modulators; Lipid peroxidation modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Alzheimer's disease; Friedreich's ataxia; Mitochondrial myopathies; Parkinson's disease; Retinal disorders

Most Recent Events

  • 16 Sep 2016 Preclinical research in Alzheimer's disease in USA (unspecified route)
  • 16 Sep 2016 Preclinical research in Mitochondrial myopathies in USA (unspecified route)
  • 16 Sep 2016 Preclinical research in Parkinson's disease in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top